Mrs Kimberly Andrews Caton, ALC | |
172 Belmont Dr, Dothan, AL 36305-6504 | |
(334) 671-1280 | |
(334) 671-0475 |
Full Name | Mrs Kimberly Andrews Caton |
---|---|
Gender | Female |
Speciality | Counselor |
Location | 172 Belmont Dr, Dothan, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023763166 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101Y00000X | Counselor | C3982A (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Kimberly Andrews Caton, ALC 187 Belmont Dr, Dothan, AL 36305-6500 Ph: (334) 671-1280 | Mrs Kimberly Andrews Caton, ALC 172 Belmont Dr, Dothan, AL 36305-6504 Ph: (334) 671-1280 |
News Archive
Curemark, LLC,, a drug research and development company focused on the treatment of neurological diseases, announced that the company has opened clinical trial enrollment for CM-AT, its autism treatment, at the University of Pittsburgh and the Alexian Brothers Behavioral Health Hospital in Hoffman Estates, Illinois, near Chicago. A total of 12 sites nationwide are recruiting patients for CM-AT Phase III clinical trials.
MedeAnalytics, a leading provider of healthcare performance management solutions, announced today that Alameda Alliance for Health, based in Alameda, Calif., has selected MedeAnalytics' Provider Network Management Analytics and Medical Management Analytics solutions. The Alliance will utilize these analytic solutions to improve member outcomes and services.
More young people are having strokes while older people are having fewer, according to data from Ohio and Kentucky presented at the American Stroke Association's International Stroke Conference 2010.
A new study, released as a preprint on the bioRxiv* server, reports an optimized coronavirus disease 2019 (COVID-19) vaccine candidate, which, claim the researchers, may be less likely to produce reactions like fevers. It may also have increased protective potential against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen that causes COVID-19.
Vical Incorporated (NASDAQ:VICL) today announced that results from a Phase I clinical trial of a DNA vaccine for severe acute respiratory syndrome (SARS), conducted by the National Institutes of Health (NIH) and published in the November 25 issue of Vaccine(1), demonstrated that the vaccine was well-tolerated, and induced neutralizing antibody responses in 80% of the vaccinees and T-cell immune responses in all vaccinees.
› Verified 1 days ago
Mr. Bradford Lee Bullard, LIC PROFESSIONAL COU Counselor Medicare: Not Enrolled in Medicare Practice Location: 187 Belmont Drive, Dothan, AL 36305 Phone: 334-671-1280 Fax: 334-671-0475 | |
Mrs. Lori Lynn Chancy, MS, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 Medical Dr, Dothan, AL 36303 Phone: 334-702-7222 Fax: 334-712-0972 | |
Mary J Strother, L.P.C. Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 Medical Dr, Dothan, AL 36303 Phone: 334-702-7222 Fax: 334-712-0972 | |
Mrs. Emrist Anne Mustin, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 101 Medical Dr, Dothan, AL 36303 Phone: 334-702-7222 | |
Donda Goodson, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 105 Preswick Dr, Dothan, AL 36305 Phone: 334-790-8362 | |
Mrs. Terry Denise Bradley, MS, LPC Counselor Medicare: Medicare Enrolled Practice Location: 2431 W Main St, Suite 603, Dothan, AL 36301 Phone: 334-673-8869 Fax: 334-673-8851 |